Advertisement

Topics

Sanofi-Aktie: Ergebnis-Ausblick nach solidem Quartal angehoben - Aktienanalyse

07:04 EDT 4 Aug 2017 | FinanzNachrichten

Frankfurt - Sanofi-Aktienanalyse von Aktienanalyst Bernhard Weininger von Independent Research: Bernhard Weininger, Aktienanalyst von Independent Research, senkt in einer aktuellen Aktienanalyse se...

Original Article: Sanofi-Aktie: Ergebnis-Ausblick nach solidem Quartal angehoben - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "Sanofi-Aktie: Ergebnis-Ausblick nach solidem Quartal angehoben - Aktienanalyse"

Quick Search
Advertisement
 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...